The APOB gene makes a protein that helps package and carry cholesterol and other fats in the blood. If it does not work properly, LDL cholesterol may become very high in some people, while others may have unusually low blood fats and trouble absorbing fat soluble vitamins. This gene helps your body move fats to the liver and other tissues, so certain variants can be linked to inherited cholesterol conditions and, in some families, a higher chance of early heart disease.
What is a gene?
Genes are sections of DNA that give cells instructions for making molecules or for managing processes throughout the body. Some genes provide the code to make proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they take place, and how active they are. In combination, genes affect how your body develops and functions, and they can influence your response to food, stress, and medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
APOBGene function
What if the gene works
The APOB gene makes a protein that helps carry cholesterol and other fats through the blood. It lets the liver package fats into lipoproteins and helps cells take up LDL cholesterol.
Risk
What if the gene does not work
Variants in the APOB gene can raise LDL cholesterol and heart disease risk, or lower APOB levels and affect fat handling and the liver. Effects range from mild to more marked, depending on the variant.
Treatment
What does that mean for your treatment
No single APOB-specific treatment plan applies across APOB-related conditions. For severe loss-of-function variants, care often includes a low-fat diet and vitamins E, A, D, and K. For APOB variants linked to high LDL cholesterol, treatment usually follows standard LDL-lowering care rather than a different gene-based drug choice. APOB is also a drug target, and some therapies lower apoB production or the cholesterol-carrying particles in blood for selected rare lipid conditions.
Conditions associated with APOB
Gene function
What if the gene works
Your body uses the APOB gene to package and move fats, including cholesterol and triglycerides, through the bloodstream. It helps build the particles that carry these fats from the intestine and liver to other tissues. This is part of how the APOB gene helps move cholesterol through the bloodstream each day. Cells then receive fuel and key building blocks.
The APOB gene provides the main protein framework for several fat carrying particles in blood. That framework keeps the particles stable enough to carry cholesterol and triglycerides through a watery environment.
In the intestine, the APOB gene helps package fat from food after a meal. These particles carry triglycerides, cholesterol, and fat soluble vitamins from the gut into the bloodstream.
In the liver, this gene supports particles that send out triglycerides and cholesterol handled by your body. This helps supply tissues with fuel between meals and during daily activity.
A longer APOB protein helps certain cholesterol carrying particles attach to LDL receptors, which are docking sites on cells. This allows the liver and other tissues to take up these particles in a controlled way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the APOB gene can change the shape, length, or binding ability of apolipoprotein B, which helps explain how APOB gene variants affect cholesterol transport. Some missense variants weaken binding to the LDL receptor, so LDL particles are cleared less efficiently, while shortening variants can reduce how well lipoprotein particles are assembled or released. These changes range from milder to more severe, and that can influence whether cholesterol changes are modest or more marked, and when related features appear.
How variants are linked to conditions
Pathogenic variants in the APOB gene are a well-established cause of familial hypercholesterolemia, so discussions of the APOB gene and high cholesterol usually focus on this inherited condition. Other APOB variants cause familial hypobetalipoproteinemia, which leads to unusually low cholesterol and can also affect the liver or vitamin levels. Common APOB differences have also been linked to smaller changes in cholesterol levels and heart disease risk.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For some APOB changes that raise LDL cholesterol, risk is shaped not only by the variant but also by family history and other factors such as smoking, diabetes, high blood pressure, and higher saturated fat intake. Healthy habits can help lower heart disease risk, but they do not erase the inherited cholesterol risk.
Inheritance of APOB variants
APOB inheritance depends on the specific condition linked to the variant. For example, some APOB-related conditions, including certain forms of familial hypercholesterolemia, follow an autosomal dominant pattern, so a parent with the variant can pass it to each child with a 50% chance. Other APOB-related conditions, such as familial hypobetalipoproteinemia, can show a different pattern because one changed copy and two changed copies do not affect health in the same way. Because the APOB gene is on chromosome 2, variants can be inherited from either parent and can be passed to sons and daughters equally.
What does my APOB result mean for my family?
What an APOB result means for family members depends on which APOB-related condition the result is tied to. Some APOB changes that raise LDL cholesterol and heart disease risk often run in families in a dominant pattern, so close relatives may also carry the same change and may want to discuss testing. Other APOB changes are linked to very low cholesterol and fatty liver, and family members may be affected in different ways depending on whether they carry one changed copy or two.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the APOB gene, a lab can use genetic testing for APOB inherited high cholesterol on a blood sample or cheek swab. The test reads your DNA and looks for changes linked to familial hypercholesterolemia, which can help clarify whether APOB is part of the reason cholesterol runs high in your family.
When should I consider getting a genetic test?
Consider APOB testing if you or close relatives have very high LDL (“bad”) cholesterol, especially from a young age, or a strong family history of early heart disease. It can help show whether an inherited cholesterol condition is present and whether relatives may also need testing.
A genetic result is only one part of your health story
Genetic test findings can offer useful insight, but what they reveal depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes affect the way people respond to medications. It examines relationships between genes and drugs to help explain why the same treatment does not work in exactly the same way for everyone. With many medicines, genes can influence how strongly a drug works or how the body processes it. This understanding can support more informed, individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the APOB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so concerns about medicines, side effects, or cholesterol are best discussed with your doctor. APOB has been studied for possible links to response to cholesterol-lowering treatment, but those findings are not strong enough to guide care on their own.
History
In recent decades, awareness of the APOB gene’s role in cholesterol has grown. Researchers first identified apolipoprotein B as a major part of LDL, often called “bad” cholesterol, during the rise of modern heart disease research in the 1960s and 1970s. Building on this early work, scientists linked changes in the APOB gene to inherited high cholesterol, helping explain why some families developed early heart disease despite otherwise similar lifestyles. In the late 1980s and early 1990s, studies showed that certain APOB variants could disrupt how LDL is cleared from the blood. This helped separate APOB related inherited high cholesterol from other genetic causes, such as variants in the LDLR gene. These discoveries became part of the broader shift toward DNA based diagnosis in cardiovascular medicine.